UK News
-
Gene variants reveal susceptibility to Crohn’s disease
Variants in ten genes that increase an individual’s susceptibility to Crohn’s disease have been identified for the first time, thanks the largest study to date on the subject, it was announced last night. Read more
-
Statin users should ‘continue’ with the therapy
Stopping statin treatment early could substantially reduce lifetime protection against heart disease because most of the benefit occurs late in life, a major conference is to hear. Read more
-
Scientists unveil synthetic embryo
A synthetic embryo, created in a British laboratory, has a beating heart and the foundations of a brain, scientists have announced. Read more
-
Blood test potential to diagnose early aggressive lung cancer
A simple blood test could help to diagnose and characterise the most aggressive form of lung cancer, scientists have revealed. Read more
-
Progress on microsurgery
German surgeons say they are the first to undertake fully robot-supported microsurgical operations on human patients. Read more
-
New insights into COVID-19 infectiousness
British researchers have unveiled the first real-world study to estimate how long people are infectious with mild COVID-19. Read more
-
Trusted professionals could boost pregnant women’s COVID-19 vaccination rates
Low COVID-19 vaccination rates among pregnant women could be increased if there was better communication from trusted midwives and GPs, according to new research. Read more
-
Genetic risk testing for prostate cancer could lead to earlier diagnosis
Incorporating testing for genetic risk for prostate cancer into GP triage and referral processes could lead to earlier diagnosis, researchers say today. Read more
-
Rise in intravenous nutrition use among athletes
Elite sport players in European and America are increasingly turning to intravenous nutrition products, experts warn today. Read more
-
UK approves the first bivalent COVID-19 booster vaccine
A bivalent COVID-19 vaccine, targeting the original strain and the Omicron variant, has been approved for use in the UK for the first time. Read more
